Skip to main content
. Author manuscript; available in PMC: 2012 Jul 1.
Published in final edited form as: Circ Cardiovasc Qual Outcomes. 2011 Jun 21;4(4):399–407. doi: 10.1161/CIRCOUTCOMES.110.959809

Table 4.

Odds of controlled BP (<140/90 mmHg) within 6 months post stroke hospitalization (n=2054 unadjusted)

BP uncontrolled
N=673 (%)
BP controlled
N=1381(%)
Unadjusted OR
(95% CI)
Adjusted OR*
(95%CI)
Gender
    Male 97.4 97.4 Ref Ref
    Female 2.6 2.6 0.97 (0.54, 1.74) 0.87 (0.47, 1.62)
Age
    <65 53.8 49.1 Ref Ref
    65–74 21.6 22.0 1.12 (0.88, 1.42) 1.25 (0.96, 1.63)
    75+ 24.6 28.9 1.28 (1.03, 1.61) 1.23 (0.95, 1.59)
Race*
    White 59.8 69.1 Ref Ref
    Black 30.0 24.2 0.69 (0.55, 0.86) 0.84 (0.66, 1.06)
    Other 10.0 6.8 0.59 (0.41, 0.84) 0.63 (0.44, 0.91)
N Co-morbidities at admission (mean± SD) 3.4 ± 2.0 3.5 ± 2.0 1.03 (0.98, 1.08) 1.06 (0.96, 1.17)
Co-morbidities
    Cerebrovascular disease 24.6 28.0 1.20 (0.97, 1.49) 1.16 (0.89, 1.50)
    CVD 32.6 36.5 1.19 (0.98,1.45) 1.02 (0.76, 1.36)
    Diabetes 46.2 40.2 0.78 (0.65, 0.94) 0.81 (0.64, 1.03)
    Hypertension 87.0 77.3 0.51 (0.39, 0.66) 0.52 (0.38, 0.71)
    Hyperlipidemia 50.8 54.2 1.15 (0.95, 1.38) 1.08 (0.86, 1.37)
Systolic BP at Discharge mmHg (mean± SD) 141 ± 22 133 ± 19 0.98 (0.98, 0.99) 0.99 (0.98, 0.99)
Diastolic BP at Discharge mmHg (mean± SD) 79 ±14 75 ± 12 0.97 (0.97, 0.98) 0.99 (0.98,1.00)
N Visits Post Discharge (mean± SD) 5.8 ± 4.9 6.2 ±4.8 1.02 (1.00, 1.04) 1.02 (0.99, 1.04)
Antihypertensives at DC
    Thiazide + ACE/ ARB 18.2 15.9 0.85 (0.66, 1.08) 1.20 (0.88, 1.62)
    Thiazide 6.4 6.7 1.06 (0.72, 1.54) 1.24 (0.80, 1.91)
    ACE/ARB 40.2 39.8 0.98 (0.81, 1.19) 1.09 (0.86, 1.39)
    Beta Blockers 52.0 47.6 0.84 (0.70, 1.01) 0.90 (0.72, 1.11)
    CCB 31.6 25.3 0.73 (0.60, 0.90) 0.90 (0.72, 1.13)
    All other classes 33.6 31.0 0.89 (0.73, 1.08) 0.89 (0.71, 1.11)
*

One hundred thirty-nine patients were missing race information-- BP uncontrolled N= 45 (6.7%) and BP controlled N=94 (6.8%). The resulting adjusted logistic model had 1915 patients and included the variables gender, age, race, history of cardiovascular disease, cerebrovascular disease, Diabetes, hypertension, hyperlipidemia, number of co-morbidities at admission, systolic and diastolic BP at discharge, number of visits since hospital discharge, class of antihypertensive drugs prescribed at discharge. Facility was a random effect (N=125)